home / stock / inbp / inbp quote
Last: | $0.20 |
---|---|
Change Percent: | 12.5% |
Open: | $0.175 |
Close: | $0.20 |
High: | $0.2 |
Low: | $0.175 |
Volume: | 2,869 |
Last Trade Date Time: | 07/15/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.2 | $0.175 | $0.2 | $0.2 | $0.175 | 2,869 | 07-15-2024 |
$0.2 | $0.2 | $0.2 | $0.2 | $0.2 | 2,150 | 07-01-2024 |
$0.21 | $0.21 | $0.21 | $0.21 | $0.21 | 300 | 06-28-2024 |
$0.2 | $0 | $0.2 | $0 | $0 | 40 | 06-25-2024 |
$0.2 | $0.173 | $0.2 | $0.2 | $0.173 | 460 | 06-24-2024 |
$0.22316 | $0 | $0.22316 | $0 | $0 | 5 | 06-14-2024 |
$0.22316 | $0.173 | $0.22316 | $0.22316 | $0.173 | 310 | 06-12-2024 |
$0.24 | $0.24 | $0.24 | $0.24 | $0.24 | 1,041 | 06-10-2024 |
$0.25 | $0.25 | $0.25 | $0.25 | $0.25 | 100 | 05-29-2024 |
$0.25 | $0.25 | $0.25 | $0.25 | $0.1806 | 1,900 | 05-28-2024 |
$0.2485 | $0.2485 | $0.2485 | $0.2485 | $0.2485 | 2,000 | 05-27-2024 |
$0.2485 | $0.2485 | $0.2485 | $0.2485 | $0.2485 | 2,000 | 05-24-2024 |
$0.22 | $0.229 | $0.22 | $0.229 | $0.22 | 6,015 | 05-23-2024 |
$0.22 | $0.22 | $0.22 | $0.22 | $0.22 | 100 | 05-14-2024 |
$0.217 | $0.1806 | $0.217 | $0.217 | $0.1806 | 504 | 05-13-2024 |
$0.2182 | $0.2182 | $0.2182 | $0.2182 | $0.2182 | 500 | 05-09-2024 |
$0.1806 | $0.1806 | $0.1806 | $0.1806 | $0.1806 | 1,000 | 05-08-2024 |
$0.19059 | $0.21 | $0.19059 | $0.21 | $0.19059 | 11,680 | 05-03-2024 |
$0.19089 | $0.1808 | $0.19089 | $0.19089 | $0.1808 | 8,000 | 05-02-2024 |
$0.21 | $0.1806 | $0.21 | $0.21 | $0.1806 | 2,249 | 04-30-2024 |
News, Short Squeeze, Breakout and More Instantly...
Integrated Biopharma Inc Company Name:
INBP Stock Symbol:
OTCMKTS Market:
Integrated Biopharma Inc Website:
HILLSIDE, NJ / ACCESSWIRE / May 10, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2024. Revenue for each of the quarters ended March 31, 2024 and 2023 were approximately $13.1 million. The Company had opera...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
HILLSIDE, NJ / ACCESSWIRE / February 12, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2023. Revenue for the quarter ended December 31, 2023 was $11.5 million compared to $12.3 million for the quarter ...